These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 3028435
1. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists. Losert W, Bittler D, Buse M, Casals-Stenzel J, Haberey M, Laurent H, Nickisch K, Schillinger E, Wiechert R. Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435 [Abstract] [Full Text] [Related]
5. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists. Casals-Stenzel J, Buse M, Wambach G, Losert W. Arzneimittelforschung; 1984 Nov; 34(3):241-6. PubMed ID: 6329237 [Abstract] [Full Text] [Related]
6. Antiandrogenic effect of spirolactones: mechanism of action. Corvol P, Michaud A, Menard J, Freifeld M, Mahoudeau J. Endocrinology; 1975 Jul; 97(1):52-8. PubMed ID: 166833 [Abstract] [Full Text] [Related]
8. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. de Gasparo M, Joss U, Ramjoué HP, Whitebread SE, Haenni H, Schenkel L, Kraehenbuehl C, Biollaz M, Grob J, Schmidlin J. J Pharmacol Exp Ther; 1987 Feb; 240(2):650-6. PubMed ID: 2949071 [Abstract] [Full Text] [Related]
9. Inhibitory effects of the novel anti-aldosterone compound mespirenone on adrenocortical steroidogenesis in vitro. Weindel K, Lewicka S, Vecsei P. Arzneimittelforschung; 1991 Sep; 41(9):946-9. PubMed ID: 1796922 [Abstract] [Full Text] [Related]